{
  "pmid": "34333849",
  "uid": "34333849",
  "title": "Increased potency of recombinant VWF D'D3 albumin fusion proteins engineered for enhanced affinity for coagulation factor VIII.",
  "abstract": "BACKGROUND: We have recently reported on a recombinant von Willebrand factor (VWF) D'D3 albumin fusion protein (rD'D3-FP) developed to extend the half-life of coagulation factor VIII (FVIII) for the treatment of hemophilia A. Based on predictive modelling presented in this study, we hypothesized that modifying rD'D3-FP to improve FVIII interaction would reduce exchange with endogenous VWF and provide additional FVIII half-life benefit. OBJECTIVES: The aim of this study was to identify novel rD'D3-FP variants with enhanced therapeutic efficacy in extending FVIII half-life. METHODS: Through both directed mutagenesis and random mutagenesis using a novel mammalian display platform, we identified novel rD'D3-FP variants with increased affinity for FVIII (rVIII-SingleChain) under both neutral and acidic conditions and assessed their ability to extend FVIII half-life in vitro and in vivo. RESULTS: In rat preclinical studies, rD'D3-FP variants with increased affinity for FVIII displayed enhanced potency, with reduced dose levels required to achieve equivalent rVIII-SingleChain half-life extension. In cell-based imaging studies in vitro, we also demonstrated reduced dissociation of rVIII-SingleChain from the rD'D3-FP variants within acidic endosomes and more efficient co-recycling of the rD'D3-FP/rVIII-SingleChain complex via the FcRn recycling system. CONCLUSIONS: In summary, at potential clinical doses, the rD'D3-FP variants provide marked benefits with respect to dose levels and half-life extension of co-administered FVIII, supporting their development for use in the treatment of hemophilia A.",
  "authors": [
    {
      "last_name": "Chia",
      "fore_name": "Jenny",
      "initials": "J",
      "name": "Jenny Chia",
      "affiliations": [
        "CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia."
      ],
      "orcid": "0000-0001-6247-3346"
    },
    {
      "last_name": "Pestel",
      "fore_name": "Sabine",
      "initials": "S",
      "name": "Sabine Pestel",
      "affiliations": [
        "CSL Behring GmbH, Marburg, Germany."
      ]
    },
    {
      "last_name": "Glauser",
      "fore_name": "Isabelle",
      "initials": "I",
      "name": "Isabelle Glauser",
      "affiliations": [
        "CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia."
      ]
    },
    {
      "last_name": "Emmrich",
      "fore_name": "Kerstin",
      "initials": "K",
      "name": "Kerstin Emmrich",
      "affiliations": [
        "CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia."
      ]
    },
    {
      "last_name": "Hardy",
      "fore_name": "Matthew P",
      "initials": "MP",
      "name": "Matthew P Hardy",
      "affiliations": [
        "CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia."
      ]
    },
    {
      "last_name": "Mischnik",
      "fore_name": "Marcel",
      "initials": "M",
      "name": "Marcel Mischnik",
      "affiliations": [
        "CSL Behring GmbH, Marburg, Germany."
      ]
    },
    {
      "last_name": "Raquet",
      "fore_name": "Elmar",
      "initials": "E",
      "name": "Elmar Raquet",
      "affiliations": [
        "CSL Behring GmbH, Marburg, Germany."
      ]
    },
    {
      "last_name": "Tomasetig",
      "fore_name": "Vesna",
      "initials": "V",
      "name": "Vesna Tomasetig",
      "affiliations": [
        "CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia."
      ]
    },
    {
      "last_name": "Claar",
      "fore_name": "Philipp",
      "initials": "P",
      "name": "Philipp Claar",
      "affiliations": [
        "CSL Behring GmbH, Marburg, Germany."
      ]
    },
    {
      "last_name": "Zalewski",
      "fore_name": "Anton",
      "initials": "A",
      "name": "Anton Zalewski",
      "affiliations": [
        "CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia."
      ]
    },
    {
      "last_name": "Bass",
      "fore_name": "Gregory T",
      "initials": "GT",
      "name": "Gregory T Bass",
      "affiliations": [
        "CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia."
      ]
    },
    {
      "last_name": "Turnbull",
      "fore_name": "Victor",
      "initials": "V",
      "name": "Victor Turnbull",
      "affiliations": [
        "CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia."
      ]
    },
    {
      "last_name": "Chen",
      "fore_name": "Chao-Guang",
      "initials": "CG",
      "name": "Chao-Guang Chen",
      "affiliations": [
        "CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia."
      ]
    },
    {
      "last_name": "Wilson",
      "fore_name": "Michael J",
      "initials": "MJ",
      "name": "Michael J Wilson",
      "affiliations": [
        "CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia."
      ]
    },
    {
      "last_name": "Panousis",
      "fore_name": "Con",
      "initials": "C",
      "name": "Con Panousis",
      "affiliations": [
        "CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia."
      ]
    },
    {
      "last_name": "Weimer",
      "fore_name": "Thomas",
      "initials": "T",
      "name": "Thomas Weimer",
      "affiliations": [
        "CSL Behring GmbH, Marburg, Germany."
      ]
    },
    {
      "last_name": "Andrews",
      "fore_name": "Arna",
      "initials": "A",
      "name": "Arna Andrews",
      "affiliations": [
        "CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia."
      ]
    },
    {
      "last_name": "Verhagen",
      "fore_name": "Anne M",
      "initials": "AM",
      "name": "Anne M Verhagen",
      "affiliations": [
        "CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia."
      ]
    },
    {
      "last_name": "Dower",
      "fore_name": "Steve K",
      "initials": "SK",
      "name": "Steve K Dower",
      "affiliations": [
        "CSL Limited, Bio21 Molecular Science and Biotechnology Institute, Parkville, Victoria, Australia."
      ]
    }
  ],
  "journal": {
    "title": "Journal of thrombosis and haemostasis : JTH",
    "iso_abbreviation": "J Thromb Haemost",
    "issn": "1538-7836",
    "issn_type": "Electronic",
    "volume": "19",
    "issue": "11",
    "pub_year": "2021",
    "pub_month": "Nov"
  },
  "start_page": "2710",
  "end_page": "2725",
  "pages": "2710-2725",
  "language": "eng",
  "publication_types": [
    "Journal Article"
  ],
  "keywords": [
    "Albumins",
    "Animals",
    "Factor VIII",
    "Hemophilia A",
    "Rats",
    "Recombinant Fusion Proteins",
    "Recombinant Proteins",
    "von Willebrand Factor"
  ],
  "article_ids": {
    "pubmed": "34333849",
    "doi": "10.1111/jth.15480",
    "pii": "S1538-7836(22)00471-8"
  },
  "doi": "10.1111/jth.15480",
  "dates": {
    "completed": "2021-10-27",
    "revised": "2023-08-29"
  },
  "chemicals": [
    "Albumins",
    "Recombinant Fusion Proteins",
    "Recombinant Proteins",
    "von Willebrand Factor",
    "Factor VIII"
  ],
  "grants": [],
  "search_metadata": {
    "search_type": "all_publications",
    "retrieved_date": "2025-07-30T15:10:00.704423",
    "pmid": "34333849"
  }
}